Abstract
Primary antibody deficiencies (PADs) are the most common inherited primary immunodeficiencies in humans, characterized by hypogammaglobulinemia, an inability to produce specific antibodies, and recurrent infections mainly caused by encapsulated bacteria. However, it has been shown that inflammatory disorders, granulomatous lesions, lymphoproliferative diseases, cancer, and autoimmunity are associated with the various types of PAD. Both systemic and organ-specific autoimmune diseases could be attributed to B-cell defects in PAD patients. Immune thrombocytopenic purpura and autoimmune hemolytic anemia are the most common autoimmune disorders in this group of patients. The aim of this review is to describe the proposed mechanisms for autoimmunity and to review the literature with respect to the reported autoimmune disorders in each type of PAD.
References
1.
Abolhassani H, Parvaneh N, Rezaei N, Hammarstrom L, Aghamohammadi A: Genetic defects in B-cell development and their clinical consequences. J Investig Allergol Clin Immunol 2014;24:6-22.
2.
Durandy A, Kracker S, Fischer A: Primary antibody deficiencies. Nat Rev Immunol 2013;13:519-533.
3.
Aghamohammadi A, Allahverdi A, Abolhassani H, Moazzami K, Alizadeh H, Gharagozlou M, et al: Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010;15:289-295.
4.
Mamishi S, Eghbali AN, Rezaei N, Abolhassani H, Parvaneh N, Aghamohammadi A: A single center 14 years study of infectious complications leading to hospitalization of patients with primary antibody deficiencies. Braz J Infect Dis 2010;14:351-355.
5.
Patel SS, Fergeson JE, Glaum MC, Lockey RF: Symptomatic primary selective immunoglobulin M deficiency with nonprotective pneumococcal titers responsive to subcutaneous immunoglobulin treatment. Int Arch Allergy Immunol 2016;170:138-140.
6.
Xiao X, Miao Q, Chang C, Gershwin ME, Ma X: Common variable immunodeficiency and autoimmunity - an inconvenient truth. Autoimmun Rev 2014;13:858-864.
7.
Rahiminejad MS, Mirmohammad Sadeghi M, Mohammadinejad P, Sadeghi B, Abolhassani H, Dehghani Firoozabadi MM, et al: Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura. Iran J Allergy Asthma Immunol 2013;12:50-56.
8.
Abolhassani H, Gharib B, Shahinpour S, Masoom SN, Havaei A, Mirminachi B, et al: Autoimmunity in patients with selective IgA deficiency. J Investig Allergol Clin Immunol 2015;25:112-119.
9.
Cunningham-Rundles C: Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 2008;28(suppl 1):S42-S45.
10.
Abolhassani H, Amirkashani D, Parvaneh N, Mohammadinejad P, Gharib B, Shahinpour S, et al: Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2013;23:323-329.
11.
Patiroglu T, Gungor HE, Unal E: Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia. Acta Microbiol Immunol Hung 2012;59:343-353.
12.
Fried AJ, Bonilla FA: Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev 2009;22:396-414.
13.
Glocker E, Grimbacher B: Inflammatory bowel disease: is it a primary immunodeficiency? Cell Mol Life Sci 2012;69:41-48.
14.
Lavrador V, Correia F, Sampaio R, Candido C, Sameiro-Faria M, Marques L, et al: Membranoproliferative glomerulonephritis and x-linked agammaglobulinemia: an uncommon association. Case Rep Pediatr 2014;2014:480947.
15.
Cunningham-Rundles C: Hematologic complications of primary immune deficiencies. Blood Rev 2002;16:61-64.
16.
LeBien TW, Tedder TF: B lymphocytes: how they develop and function. Blood 2008;112:1570-1580.
17.
Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al: Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2014;5:162.
18.
Gathmann B, Binder N, Ehl S, Kindle G, Party ERW: The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol 2012;167:479-491.
19.
Kindle G, Gathmann B, Grimbacher B: The use of databases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2014;14:501-508.
20.
Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al: The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol 2014;175:68-78.
21.
Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al: Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol 2014;34:478-490.
22.
Mila Llambi J, Etxagibel Galdos A, Matamoros Flori N: The Spanish Registry of Primary Immunodeficiencies (REDIP) (in Spanish). Allergol Immunopathol 2001;29:122-125.
23.
Plebani A, Soresina A, Notarangelo LD, Quinti I, Mattia DD, Moschese V, et al: The Italian network of primary immunodeficiencies. Iran J Allergy Asthma Immunol 2004;3:165-168.
24.
Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, et al: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003;4:261-268.
25.
Schaffer AA, Salzer U, Hammarstrom L, Grimbacher B: Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007;17:201-212.
26.
van Zelm MC, Smet J, Adams B, Mascart F, Schandene L, Janssen F, et al: CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010;120:1265-1274.
27.
Thiel J, Kimmig L, Salzer U, Grudzien M, Lebrecht D, Hagena T, et al: Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012;129:801.e6-810.e6.
28.
Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, et al: CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Investig 2010;120:214-222.
29.
Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, et al: LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 2012;130:481.e2-488.e2.
30.
Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, et al: Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012;366:330-338.
31.
Wang HY, Ma CA, Zhao Y, Fan X, Zhou Q, Edmonds P, et al: Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. Proc Natl Acad Sci USA 2013;110:5127-5132.
32.
Meffre E: The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann NY Acad Sci 2011;1246:1-10.
33.
Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al: Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009;27:199-227.
34.
Bolon B: Cellular and molecular mechanisms of autoimmune disease. Toxicol Pathol 2012;40:216-229.
35.
Arason GJ, Jorgensen GH, Ludviksson BR: Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol 2010;71:317-328.
36.
Azizi G, Ghanavatinejad A, Abolhassani H, Yazdani R, Rezaei N, Mirshafiey A, et al: Autoimmunity in primary T-cell immunodeficiencies. Expert Rev Clin Immunol 2016;12:989-1006.
37.
Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Rezaei N, Ochs HD, Aghamohammadi A: Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol 2016, Epub ahead of print.
38.
Coutinho A, Carneiro-Sampaio M: Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease. J Clin Immunol 2008;28(suppl 1):S4-S10.
39.
Arandi N, Mirshafiey A, Jeddi-Tehrani M, Abolhassani H, Sadeghi B, Mirminachi B, et al: Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol 2013;281:129-133.
40.
Westerberg LS, Klein C, Snapper SB: Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency - lessons learned from monogenic disorders in mice and men. Curr Opin Immunol 2008;20:646-654.
41.
Arumugakani G, Wood PM, Carter CR: Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. J Clin Immunol 2010;30:292-300.
42.
Atkinson TP: Immune deficiency and autoimmunity. Curr Opin Rheumatol 2012;24:515-521.
43.
Grammatikos AP, Tsokos GC: Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends Mol Med 2012;18:101-108.
44.
Sharfe N, Merico D, Karanxha A, Macdonald C, Dadi H, Ngan B, et al: The effects of RelB deficiency on lymphocyte development and function. J Autoimmun 2015;65:90-100.
45.
Barsotti NS, Almeida RR, Costa PR, Barros MT, Kalil J, Kokron CM: IL-10-producing regulatory B cells are decreased in patients with common variable immunodeficiency. PLoS One 2016;11:e0151761.
46.
Pillai S: Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun 2013;45:97-103.
47.
Chew GY, Sinha U, Gatenby PA, DeMalmanche T, Adelstein S, Garsia R, et al: Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22). J Allergy Clin Immunol 2013;131:1130.e1-1135.e1.
48.
Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR: From infection to autoimmunity. J Autoimmun 2001;16:175-186.
49.
Panoutsakopoulou V, Cantor H: On the relationship between viral infection and autoimmunity. J Autoimmun 2001;16:341-345.
50.
Arkwright PD, Abinun M, Cant AJ: Autoimmunity in human primary immunodeficiency diseases. Blood 2002;99:2694-2702.
51.
Nonoyama S, Tsukada S, Yamadori T, Miyawaki T, Jin YZ, Watanabe C, et al: Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia. J Immunol 1998;161:3925-3929.
52.
Ng YS, Wardemann H, Chelnis J, Cunningham-Rundles C, Meffre E: Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med 2004;200:927-934.
53.
Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E: Human B cell tolerance and its failure in rheumatoid arthritis. Ann NY Acad Sci 2005;1062:116-126.
54.
Corneth OB, Klein Wolterink RG, Hendriks RW: BTK signaling in B cell differentiation and autoimmunity. Curr Top Microbiol Immunol 2016;393:67-105.
55.
Jacobs ZD, Guajardo JR, Anderson KM: XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol 2008;30:631-634.
56.
Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al: Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol 2014;34:627-632.
57.
Behniafard N, Aghamohammadi A, Abolhassani H, Pourjabbar S, Sabouni F, Rezaei N: Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature. Exp Rev Clin Immunol 2012;8:155-159.
58.
Sag AT, Saka E, Ozgur TT, Sanal O, Ayvaz DC, Elibol B, et al: Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy. Cogn Behav Neurol 2014;27:155-159.
59.
Tuzankina I, Kobeleva Y, Kiseleva N, Bolkov M, Reuter G, Marodi L: Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease. Allergy 2011;66:1617-1618.
60.
Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, et al: Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005;12:825-832.
61.
Yazdani R, Abolhassani H, Rezaei N, Azizi G, Hammarstrom L, Aghamohammadi A: Evaluation of known defective signaling-associated molecules in patients who primarily diagnosed as common variable immunodeficiency. Int Rev Immunol 2016;35:7-24.
62.
Yazdani R, Fatholahi M, Ganjalikhani-Hakemi M, Abolhassani H, Azizi G, Hamid KM, et al: Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency. Mol Immunol 2016;71:1-9.
63.
Costantino G, Mondello P, Previti M, Fries W, Villanacci V: Pan-digestive tract colonization by cytomegalovirus in common variable immunodeficiency. Int Arch Allergy Immunol 2014;164:30-31.
64.
Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, et al: Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol 2014;163:69-74.
65.
Rezaei N, Aghamohammadi A, Nourizadeh M, Kardar GA, Pourpak Z, Zare A, et al: Cytokine production by activated T cells in common variable immunodeficiency. Investig Allergol Clin Immunol 2010;20:244-251.
66.
Rezaei N, Aghamohammadi A, Shakiba Y, Mahmoudi M, Jalali A, Moradi B, et al: Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol 2009;150:1-7.
67.
Varzaneh FN, Keller B, Unger S, Aghamohammadi A, Warnatz K, Rezaei N: Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge. J Clin Immunol 2014;34:524-543.
68.
Kofod-Olsen E, Jorgensen SE, Nissen SK, Westh L, Moller BK, Ostergaard L, et al: Altered fraction of regulatory B and T cells is correlated with autoimmune phenomena and splenomegaly in patients with CVID. Clin Immunol 2016;162:49-57.
69.
Brandt D, Gershwin ME: Common variable immune deficiency and autoimmunity. Autoimmun Rev 2006;5:465-470.
70.
Knight AK, Cunningham-Rundles C: Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 2006;5:156-159.
71.
Karaca NE, Aksu G, Yildiz B, Gulez N, Turk B, Dereli T, et al: Relapsing polychondritis in a child with common variable immunodeficiency. Int J Dermatol 2009;48:525-528.
72.
Todoric K, Koontz JB, Mattox D, Tarrant TK: Autoimmunity in immunodeficiency. Curr Allergy Asthma Rep 2013;13:361-370.
73.
Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al: Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007;27:308-316.
74.
Milota T, Sumnik Z, Obermannova B, Kralickova P, Vondrak K, Klocperk A, et al: Negativity for specific autoantibodies in patients with type 1 diabetes that developed on a background of common variable immunodeficiency. Int Arch Allergy Immunol 2015;168:197-204.
75.
Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005;25:57-62.
76.
Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, et al: Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine 2004;83:254-263.
77.
Heeney MM, Zimmerman SA, Ware RE: Childhood autoimmune cytopenia secondary to unsuspected common variable immunodeficiency. J Pediatr 2003;143:662-665.
78.
Bateman EA, Ayers L, Sadler R, Lucas M, Roberts C, Woods A, et al: T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012;170:202-211.
79.
Yazdani R, Hakemi MG, Sherkat R, Homayouni V, Farahani R: Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency. Adv Biomed Res 2014;3:2.
80.
Boileau J, Mouillot G, Gerard L, Carmagnat M, Rabian C, Oksenhendler E, et al: Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 2011;36:25-32.
81.
Carter CR, Aravind G, Smalle NL, Cole JY, Savic S, Wood PM: CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells. J Clin Pathol 2013;66:146-150.
82.
Yu GP, Chiang D, Song SJ, Hoyte EG, Huang J, Vanishsarn C, et al: Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol 2009;131:240-253.
83.
Fevang B, Yndestad A, Sandberg WJ, Holm AM, Muller F, Aukrust P, et al: Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol 2007;147:521-525.
84.
Brouet JC, Chedeville A, Fermand JP, Royer B: Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 2000;30:2516-2520.
85.
Warnatz K, Wehr C, Drager R, Schmidt S, Eibel H, Schlesier M, et al: Expansion of CD19hiCD21lo/neg B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 2002;206:502-513.
86.
Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, et al: Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 2010;115:5026-5036.
87.
Etzioni A, Ochs HD: The hyper IgM syndrome - an evolving story. Pediatr Res 2004;56:519-525.
88.
Jesus AA, Duarte AJ, Oliveira JB: Autoimmunity in hyper-IgM syndrome. J Clin Immunol 2008;28(suppl 1):S62-S66.
89.
Gunaydin NC, Chou J, Karaca NE, Aksu G, Massaad MJ, Azarsiz E, et al: A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity. Clin Immunol 2014;153:288-291.
90.
Wiersinga WM: Thyroid autoimmunity. Endocr Dev 2014;26:139-157.
91.
Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
92.
Thakker A, Karande S: Overlap syndrome: autoimmune sclerosing cholangitis. Indian Pediatr 2010;47:1063-1065.
93.
Cosyns M, Tsirkin S, Jones M, Flavell R, Kikutani H, Hayward AR: Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun 1998;66:603-607.
94.
Schuster A, Apfelstedt-Sylla E, Pusch CM, Zrenner E, Thirkill CE: Autoimmune retinopathy with RPE hypersensitivity and ‘negative ERG' in X-linked hyper-IgM syndrome. Ocul Immunol Inflamm 2005;13:235-243.
95.
Lacroix-Desmazes S, Resnick I, Stahl D, Mouthon L, Espanol T, Levy J, et al: Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol 1999;162:5601-5608.
96.
Herve M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, et al: CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007;204:1583-1593.
97.
Tang WJ, An YF, Dai RX, Wang QH, Jiang LP, Tang XM, et al: Clinical, molecular, and T cell subset analyses in a small cohort of Chinese patients with hyper-IgM syndrome type 1. Hum Immunol 2014;75:633-640.
98.
Binek A, Jarosz-Chobot P: Selective immunoglobulin A deficiency (in Polish). Pediatr Endocrinol Diabetes Metab 2012;18:76-78.
99.
Yazdani R, Latif A, Tabassomi F, Abolhassani H, Azizi G, Rezaei N, et al: Clinical phenotype classification for selective immunoglobulin A deficiency. Exp Rev Clin Immunol 2015;11:1245-1254.
100.
Frossi B, De Carli S, Bossi F, Pucillo C, De Carli M: Co-occurrence of chronic spontaneous urticaria with immunoglobulin A deficiency and autoimmune diseases. Int Arch Allergy Immunol 2016;169:130-134.
101.
Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al: Selective IgA deficiency in autoimmune diseases. Mol Med 2011;17:1383-1396.
102.
Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, et al: Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 2004;101:3903-3908.
103.
Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, et al: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005;37:829-834.
104.
Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, Negahdari B, Mohammadi J, et al: Managing patients with side effects and adverse events to immunoglobulin therapy. Exp Rev Clin Pharmacol 2016;9:91-102.
105.
Ferreira RC, Pan-Hammarstrom Q, Graham RR, Gateva V, Fontan G, Lee AT, et al: Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet 2010;42:777-780.
106.
Jacob CM, Pastorino AC, Fahl K, Carneiro-Sampaio M, Monteiro RC: Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol 2008;28(suppl 1):S56-S61.
107.
Shkalim V, Monselize Y, Segal N, Zan-Bar I, Hoffer V, Garty BZ: Selective IgA deficiency in children in Israel. J Clin Immunol 2010;30:761-765.
108.
Edwards E, Razvi S, Cunningham-Rundles C: IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004;111:93-97.
109.
Aytekin C, Tuygun N, Gokce S, Dogu F, Ikinciogullari A: Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey. J Clin Immunol 2012;32:961-966.
110.
Schurman SH, Candotti F: Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 2003;15:446-453.
111.
Jorgensen GH, Thorsteinsdottir I, Gudmundsson S, Hammarstrom L, Ludviksson BR: Familial aggregation of IgAD and autoimmunity. Clin Immunol 2009;131:233-239.
112.
Aghamohammadi A, Abolhassani H, Biglari M, Abolmaali S, Moazzami K, Tabatabaeiyan M, et al: Analysis of switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol 2011;156:462-468.
113.
Carneiro-Sampaio M, Coutinho A: Early-onset autoimmune disease as a manifestation of primary immunodeficiency. Front Immunol 2015;6:185.
114.
Rankin EC, Isenberg DA: IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus 1997;6:390-394.
115.
Cataldo F, Lio D, Marino V, Scola L, Crivello A, Corazza GR, et al: Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency. Pediatr Allergy Immunol 2003;14:320-324.
116.
Lopez-Herrera G, Tampella G, Pan-Hammarstrom Q, Herholz P, Trujillo-Vargas CM, Phadwal K, et al: Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012;90:986-1001.
117.
Burns SO, Zenner HL, Plagnol V, Curtis J, Mok K, Eisenhut M, et al: LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. J Allergy Clin Immunol 2012;130:1428-1432.
118.
Gamez-Diaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, et al: The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol 2016;137:223-230.
119.
Charbonnier LM, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, et al: Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 2015;135:217-227.
120.
Liu Y, Song R, Gao Y, Li Y, Wang S, Liu HY, et al: Protein kinase C-delta negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome. J Biol Chem 2012;287:20081-20087.
121.
Guo B, Su TT, Rawlings DJ: Protein kinase C family functions in B-cell activation. Curr Opin Immunol 2004;16:367-373.
122.
Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, et al: Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ. Nature 2002;416:865-869.
123.
Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, et al: Protein kinase Cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum 2013;65:2161-2171.
124.
Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, et al: Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. Blood 2013;121:3117-3125.
125.
Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, et al: B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C delta. Blood 2013;121:3112-3116.
126.
Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B: Impaired T cell protein kinase Cδ activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007;179:5553-5563.
127.
Bonhomme D, Hammarström L, Webster D, Chapel H, Hermine O, Le Deist F, et al: Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 2000;165:4725-4730.
128.
Warnatz K, Denz A, Dräger R, Braun M, Groth C, Wolff-Vorbeck G, et al: Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002;99:1544-1551.
129.
Melegari A, Mascia MT, Sandri G, Carbonieri A: Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome. Ann NY Acad Sci 2007;1109:106-108.
130.
Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, et al: Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol 2011;186:4223-4233.
131.
Azizi G, Pouyani MR, Abolhassani H, Sharifi L, Dizaji MZ, Mohammadi J, et al: Cellular and molecular mechanisms of immune dysregulation and autoimmunity. Cell Immunol 2016;310:14-26.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
